Goldbank Englisch 1 - Revision history

Li Xintian: /* Part 6 */

2023-06-24T08:50:36Z

Part 6

Show changes

Li Xintian: /* Part 5 */

2023-06-24T08:30:17Z

Part 5

Li Xintian: /* Part 4 */

2023-06-24T08:13:11Z

Part 4

Show changes

Chen Yanxi at 18:36, 18 May 2023

2023-05-18T18:36:39Z

Chen Yanxi: Undo revision 155222 by Chen Yanxi (talk)

2023-05-16T10:14:04Z

Undo revision 155222 by Chen Yanxi (talk)

Show changes

Chen Yanxi at 16:36, 12 May 2023

2023-05-12T16:36:14Z

Show changes

Chen Yanxi at 16:35, 12 May 2023

2023-05-12T16:35:27Z

Show changes

Chen Yanxi at 15:46, 12 May 2023

2023-05-12T15:46:10Z

Show changes

Chen Yanxi at 11:35, 11 May 2023

2023-05-11T11:35:19Z

Show changes

Chen Yanxi at 15:52, 10 May 2023

2023-05-10T15:52:50Z

@@ Line 278: / Line 278: @@
 The medical team was led by Yan Shujiang, Deputy Director of the State Administration of Traditional Chinese Medicine, and Huang Luqi, Academician, President of the China Academy of Chinese Medical Sciences. Guang 'anmen Hospital and Xiyuan Hospital each sent six physicians and four nurses from the Respiratory, Emergency and ICU Departments to Wuhan by train, carrying N95 masks, surgical gowns and some traditional Chinese medicine and other supplies to provide TCM medical assistance.
 Earlier,Many people have arrived in Wuhan, including Tong Xiaolin, Academician of the Chinese Academy of Sciences and Chief Researcher of the China Academy of Chinese Medical Sciences, Zhang Zhongde, vice president of Guangdong Provincial Hospital of Traditional Chinese Medicine, Miao Qing, director of the Respiratory Department of Xiyuan Hospital of the China Academy of Chinese Medical Sciences, and Wang Yuguang, Director of the Respiratory Department and Director of the Pulmonary Disease Laboratory of Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University.
 Before setting out, Huang had made adequate preparations, such as reading relevant reports and scientific research articles on the epidemic, analyzing the advantages and characteristics of traditional Chinese medicine during SARS, and sorting out treatment plans; Medical teams have been set up to train medical staff in respiratory, emergency and ICU departments and coordinating and communicating with medical personnel in Wuhan to understand the situation in Wuhan and prepare protective materials.
 Jinyintan Hospital is one of the forefront and main battlefields in the fight against the epidemic. The hospital adheres to the combination of Chinese and Western medicine, promotes the full participation of traditional Chinese medicine in the treatment, builds a platform for the protection of traditional Chinese medicine, and actively improves the diagnosis and treatment plan of integrated traditional Chinese and Western medicine, which plays an important role in the fight against the epidemic.
@@ Line 290: / Line 293: @@
 On February 25, 2020, Yi Qin (the former), a medical staff from the First Hospital of Hunan University of Chinese Medicine, led patients afflicted with COVID-19 to practice Baduanjin, a way to exercise, at the Jiangxia mobile cabin hospital in Wuhan. (Photo by Shen Bohan/Xinhua News Agency)
 On February 26, 2020, in the "Mobile Emergency Intelligent Chinese Pharmacy" of Jiangxia cabin hospital, Wu Zhiting, a staff member, took down the bottles containing the single medicine listed in the prescription and scanned them one by one for confirmation and pharmaceutical preparation. (Photo by Shen Bohan/Xinhua News Agency)
 On March 4, in the latest version of the diagnosis and treatment plan released, "the prescription for removing dampness and detoxification", continuously optimized by Huang Luqi and his team according to the clinical practice, was included in the recommended prescription for severe COVID-19 patients.
 "Clinical efficacy is the gold standard for evaluating the advantages of traditional Chinese medicine," Huang Luqi said. Up to March 4, their team had treated 121 patients, including 41 discharged patients treated with traditional Chinese medicine based on syndrome differentiation and 32 discharged patients treated with integrated traditional and western medicine. The improvement rate of severe patients with COVID-19 reached 83.61%.
 As of early March, more than 3,300 medical personnel from the China Academy of Chinese Medical Sciences, Beijing University of Chinese Medicine and Chinese hospitals in Tianjin, Jiangsu, Henan, Hunan and Shaanxi formed several national medical teams to assist Hubei and Wuhan. They were stationed at key hospitals such as Wuhan Jinyintan Hospital, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, and Thunder God Mountain Hospital and also took over some mobile cabin hospitals.
@@ Line 302: / Line 310: @@
 Extended reading: A doctor's diagnosis and treatment road to recovery
 It only took two days for Zuo Dongbo to go from a doctor to a patient with COVID-19.
@@ Line 309: / Line 319: @@
 However, he did not expect how rapid the disease can go after the onset of symptoms.
 On January 7th, he began to have a severe fever and cough even badly. He took a sling on his own, which were prescribed by the outpatient service, mainly were cephalosporins etc. On the same day, Zuo Dongbo had a chest CT, which showed that there was a slight infection in the lungs.
 "I was at work on the morning of the January 9th, when my fever reached 39 degrees."
 Zuo Dongbo had a bad feeling, and his intuition told him that it was not a simple cold.
 "I have never had this kind of bad feeling. I'm always fighting fit. I love swimming. And I have never bought medicine." On January 9th, he did an extra blood test when he had the coronavirus test, and then, he had a CT scan examination.
 This time he was shocked by the result: compared with the former CT, ground-glass opacity was much more obvious, and the whole lung had GGO.
-Knowing his health condition turned worse, Zuo Dongbo was directly hospitalized in the Dongxihu District People's Hospital Infection Department. This hospital was opposite to the Second Dongxihu District Hospital which he worked at, and the office director liu was his good friend.
+Knowing his health condition turned worse, Zuo Dongbo was directly hospitalized in the Dongxihu District People's Hospital Infection Department. This hospital was opposite to the Second Dongxihu District Hospital which he worked at, and the office director Liu was his good friend.
 Being hospitalized, Zoo Dongbo was suffering from the illness. "On the way transferring to the hospital, I felt like I was dying. It's like drowning, once I stopped having HPO, I cannot breathe."
 From January 9th, moving into the Dongxihu District People’s Hospital, to January 16th, transferring to the ICU of Jinyintan Hospital, Zuo Dongbo had had his most unbearable week in his life.
@@ Line 321: / Line 337: @@
 There were four critically ill patients in the same ward. Zuo Dongbo was very upset when he watched the other three leave one by one. Before he was transferred to the mild illness ward, Zuo Dongbo suggested to take a photo with Zhang Wenying, a member of the Hubei-Supporting Medical Team of Shanghai and the nurse in charge of the neurosurgery intensive care unit of Jinshan Hospital affiliated to Fudan University, to cheer each other on.
 On January 31, Zuo Dongbo was transferred to the general ward because he did not need high flow oxygen any more.
 In the general ward, Zuo Dongbo often communicated with nurses about protection issues, and told them to pay more attention to the details of wearing and taking off. "I can't remember their looks because they wore protective clothing, but I'm really grateful to them."
 After discharge from Jinyintan hospital, Zuo Dongbo carried out an isolation observation for 14 days. After the isolation and observation period, Zuo Dongbo went to the anti-epidemic battlefield again.

← Older revision		Revision as of 18:36, 18 May 2023
Line 1:		Line 1:
−	Links to the other parts:《金銀潭》[[Goldbank_Englisch]] Part 1~~&2&3~~, [[Goldbank_Englisch_1]] Part 2, [[Goldbank_Englisch_2]] ~~Full~~	+	Links to the other parts:《金銀潭》[[Goldbank_Englisch]] Part 1, [[Goldbank_Englisch_1]] Part 2, [[Goldbank_Englisch_2]] Part 3, [[Goldbank_Englisch_3]] Part 4.

	=Part 4=		=Part 4=

@@ Line 106: / Line 106: @@
 Kaletra used in clinical research
-Led by the Institute of Biological Sciences, the study will be conducted in Jinyintan Hospital and other clinical first-line hospitals where patients with pneumonia caused by COVID-19 are treated. 761 patients will be enrolled in a randomized, double-blind, and placebo-controlled method.
+On the afternoon of February 5, the emergency research project of Ministry of Science and Technology "Research on Remdesivir Treatment of COVID-19" was launched in Jinyintan Hospital.
 With the support of the Ministry of Science and Technology, National Health Commission, State Food and Drug Administration, and other departments, the registration and approval of the clinical trial of the antiviral drug Redoxivir were completed soon, and the enrollment of the first batch of cases had been put in place.
 On Feb.6, the first batch of severe pneumonia patients infected with COVID-19 received medication, the first of which was a 68-year-old male critically ill patient admitted to Jinyintan Hospital.
-Explore the use of convalescent plasma "immune therapy"
+Exploring the use of convalescent plasma "immunity therapy"
 On Feb.13, Zhang Dingyu issued an appeal at the 23rd press conference held by Hubei Province COVID-19 Prevention and Control Headquarters: "For convalescent patients, please extend your arm and donate precious plasma to save the patients who are still fighting against COVID-19."
 "After recovery from COVID, patients have a large number of neutralizing antibodies in their bodies, which can resist the coronavirus." Zhang Dingyu said that under the premise of a lack of vaccines and specific therapeutic drugs, the use of this special immune plasma product to treat the infection of COVID is a more effective method. "The plasma donated by the convalescent patients will undergo a series of treatments to obtain a relatively purified neutralizing antibody against the coronavirus, which will be used for the treatment of critically ill patients."
 Experts believe that from the clinical pathology process, in most patients with COVID after treatment and rehabilitation, the body will produce specific antibodies against the coronavirus, which can kill and remove the virus.
 Jinyintan Hospital cooperated with relevant research teams to immediately carry out plasma collection of convalescent patients.
-People who want to donate plasma must meet three conditions: I. The age is between 18 and 60 years old; II. Confirmed infection with COVID (positive nucleic acid test); III. Discharge from the hospital after recovery for more than one week.
+On Feb.18, 2020, Cheng Lin, Zhang Dingyu's wife, came to Jinyintan Hospital, donated 400 ml of her blood. (Photo by Jinyintan Hospital, posed by Xinhua News Agency)
 Jinyintan Hospital has set up a blood collection institution on the second floor of the outpatient department. When the donor arrives at the hospital after a telephone appointment, he/she shall register his/her identity and fill in the health consultation form and informed consent form, and then conduct a health status inquiry and blood examination. After final confirmation, the blood volume collected by each donor shall be 200-400ml. After the blood collection is completed, a certain amount of economic compensation is issued to the blood donor.